Extensive personal experience: Dermopathy of graves' disease (pretibial myxedema): Long-term outcome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 438-446

  Schwartz, Kara M ^a   Fatourechi, Vahab ^b   Ahmed, Debra D F ^c   Pond, Gregory R ^c  

^a Division of Infectious Diseases and Internal Medicine   (United States)

^b Department of Dermatology ^*  (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; FLUOCINOLONE ACETONIDE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; OCTREOTIDE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE; TRIAMCINOLONE ACETATE; GLUCOCORTICOID; RADIOACTIVE IODINE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELEPHANTIASIS; ENDOCRINE OPHTHALMOPATHY; EXCISION; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; PRIORITY JOURNAL; PUNCH BIOPSY; QUESTIONNAIRE; REMISSION; RETROSPECTIVE STUDY; SKIN DISEASE; TIBIALIS ANTERIOR MUSCLE; TREATMENT OUTCOME; WOUND DRESSING; EDEMA; LEG; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; SURVIVAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; EDEMA; FEMALE; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; LEG; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYXEDEMA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN DISEASES; SURVIVAL ANALYSIS; TRIAMCINOLONE ACETONIDE;

EID: 0036169064     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.2.438     Document Type: Article

References (34)

1. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases
2. Pathogenesis and treatment of pretibial myxedema
3. Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide
4. Pretibial myxoedema: A manifestation of lymphoedema?
5. Localized myxedema and thyroid acropachy
6. Pretibial myxedema. A review of the literature and case report
7. Intralesional triamcinolone therapy for pretibial myxedema
8. Diagnostic criteria for Graves' ophthalmopathy
9. Medical treatment of Graves' ophthalmopathy
10. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema
11. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema
12. Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells
13. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease
14. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts
15. Relationship of long-acting thyroid stimulator to pretibial myxedema
16. Elephantiasic pretibial myxedema: Insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease
17. Preradial myxedema in thyroid disease
18. Is Graves' dermopathy a generalized disorder?
19. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease
20. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
21. Increased urinary excretion of acidic mucopolysaccharides in exophthalmos
22. Unusual locations of localized myxedema in Graves' disease. Report of three cases
23. Clinic correlation of pretibial myxedema with malignant exophthalmos
24. Pretibial myxedema - A reversible cause of foot drop due to entrapment of the peroneal nerve
25. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing
26. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): Downregulation of hyaluronic acid production by the lesional fibroblasts
27. Graves' dermopathy: Does octreotide scintigraphy predict the response to octreotide treatment?
28. Surgical excision of pseudotumorous pretibial myxedema
29. Pretibial myxedema
30. Corticoid therapy for pretibial myxedema. Observations on the long-acting thyroid stimulator
31. Pretibial myxedema (elephantiasic form): Treatment with cytotoxic therapy
32. Pretibial myxedema and high-dose intravenous immunoglobulin treatment
33. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis
34. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema